Response Biomedical's Q1 Sales Fall 43 Percent, Loss Increases | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical today reported that its first-quarter 2010 revenues fell 43 percent and its net loss jumped 54 percent from the first quarter of 2009.

The Vancouver, BC-based molecular diagnostics firm brought in total revenues of C$1.5 million (US$1.5 million) for the three months ended March 31, compared to C$2.7 million for the first quarter of 2009. Its clinical product sales were down around 29 percent at C$1.2 million from C$1.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.